Effects of corticosteroid use on treatment of solid tumours

Lancet

Volumn 360, Issue 9349, 2002, Pages 1969-1970

  Rutz, Hans Peter ^a  

^a PAUL SCHERRER INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLOROETHYL N NITROSUREA; CAMPTOTHECIN; CARBOPLATIN; CISPLATIN; CYTARABINE; CYTOTOXIN; DACTINOMYCIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; METHOTREXATE; NIMUSTINE; NITROSOUREA DERIVATIVE; PREDNISONE; TENIPOSIDE; UNCLASSIFIED DRUG;

CANCER CELL; CANCER PATIENT; DRUG BLOOD LEVEL; DRUG EFFECT; IN VITRO STUDY; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; SOLID TUMOR; STEROID THERAPY; TREATMENT FAILURE;

EID: 0037079310     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11922-2     Document Type: Note

References (21)

1. Frei E. III, Karon M., Levin R.H., et al. The effectiveness of combinations of antileukemic agents in inducing and maintaining remission in children with acute leukemia. Blood. 26:1965;624-656.
2. Brock W.A., Williams M., McNaney D., Milas L., Peters L.J., Weichselbaum R.R. Modification by dexamethasone of radiation response of in vitro cultured cells. Int J Radiat Oncol Biol Phys. 10:1984;2113-2117.
3. Renan M.J., Dowman P.I. Increased radioresistance of tumor cells exposed to metallothionein-inducing agents. Radiat Res. 120:1989;442-455.
4. Brady M.E., Sartiano G.P., Rosenblum S.L., Zaglama N.E., Bauguess C.T. The pharmacokinetics of single high doses of dexamethasone in cancer patients. Eur J Clin Pharmacol. 32:1987;593-596.
5. Orth D.N., Kovacs W.J., Debold C.R. Molecular mechanisms of adrenal steroid action. Wilson J.D., Foster D.W. Williams textbook of endocrinology. 8th edn:1992;513-520 W B Saunders Company, Philadelphia.
6. Bansal N., Houle A., Melnykovych G. Apoptosis: mode of cell death induced in T cell leukemia lines by dexamethasone and other agents. Faseb J. 5:1991;211-216.
7. Pruschy M., Shi Y.Q., Crompton N.E., et al. The proto-oncogene c-fos mediates apoptosis in murine T-lymphocytes induced by ionizing radiation and dexamethasone. Biochem Biophys Res Commun. 241:1997;519-524.
8. De Vita D., Hellman S., Rosenberg S.A. Cancer: principles and practice of oncology. 4th edn:1993;JB Lippincott Company, Philadelphia.
9. Aapro M.S. Present role of corticosteroids as antiemetics. Recent results in cancer research. 1991;91-100 Springer Verlag, Berlin.
10. Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. N Engl J Med. 332:1995;1-5.
11. Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy. N Engl J Med. 342:2000;1554-1559.
12. Millar B.C., Jinks S. Studies on the relationship between radiation resistance and glutathione content of human and rodent cells after treatment with dexamethasone in vitro. Int J Radiat Biol. 47:1985;539-552.
13. Rutz H.P., Mariotta M., von Knebel Doeberitz M., Mirimanoff R.O. Dexamethasone-induced radioresistance occurring independent of human papilloma virus gene expression in cervical carcinoma cells. Strahlenther Onkol. 174:1998;71-74.
14. Mariotta M., Perewusnyk G., Koechli O.R., et al. Dexamethasone-induced enhancement of resistance to ionizing radiation and chemotherapeutic agents in human tumor cells. Strahlenther Onkol. 175:1999;392-396.
15. Biswas T., Ramana C.V., Srinivasan G., et al. Activation of human O6-methylguanine-DNA methyltransferase gene by glucocorticoid hormone. Oncogene. 18:1999;525-532.
16. Karin M., Herschman H.R. Dexamethasone stimulation of metallothionein synthesis in HeLa cell cultures. Science. 204:1979;176-177.
17. Zhao J.Y., Ikeguchi M., Eckersberg T., Kuo M.T. Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells. Endocrinology. 133:1993;521-528.
18. Naumann U., Durka S., Weller M. Dexamethasone-mediated protection from drug cytotoxicity: association with p21WAF1/CIP1 protein accumulation? Oncogene. 17:1998;1567-1575.
19. Nauck M., Roth M., Tamm M., et al. Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids. Am J Respir Cell Mol Biol. 16:1997;398-406.
20. Ambrus J.L., Halpern J., Baerwald H., Johnson R.J. Cyclo-oxygenase and lipo-oxygenase inhibitors may substitute for steroid treatment in brain oedema. Lancet. 2:1985;148-149.
21. Ioannidis J.P., Hesketh P.J., Lau J. Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting: a meta-analysis of randomized evidence. J Clin Oncol. 18:2000;3409-3422.